Published in Proteomics on January 01, 2005
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int J Alzheimers Dis (2010) 1.86
Characterization of individual mouse cerebrospinal fluid proteomes. Proteomics (2014) 1.44
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. PLoS One (2011) 1.07
Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis. PLoS One (2010) 0.98
Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomics. Mol Cell Proteomics (2009) 0.94
Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis. J Cell Mol Med (2009) 0.90
Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry. J Proteome Res (2013) 0.88
Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. Am J Physiol Regul Integr Comp Physiol (2012) 0.87
Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model. PLoS One (2012) 0.84
Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. PLoS One (2014) 0.84
Total protein is an effective loading control for cerebrospinal fluid western blots. J Neurosci Methods (2015) 0.81
Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling. Clin Proteomics (2006) 0.80
A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease. J Clin Neurol (2015) 0.79
Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics. Alzheimers Dement (Amst) (2016) 0.78
Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects. Amyotroph Lateral Scler (2007) 0.78
Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery. Front Biol (Beijing) (2012) 0.77
Proteomic strategies in multiple sclerosis and its animal models. Proteomics Clin Appl (2007) 0.76
Estrogen and insulin transport through the blood-brain barrier. Physiol Behav (2016) 0.76
Quantitative proteomics comparison of arachnoid cyst fluid and cerebrospinal fluid collected perioperatively from arachnoid cyst patients. Fluids Barriers CNS (2013) 0.76
Mass spectrometric analysis of rat cerebrospinal fluid proteins following exposure to the neurotoxicant carbonyl sulfide. Rapid Commun Mass Spectrom (2014) 0.75
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67
Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology (2005) 3.83
Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A (2008) 3.41
FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho. J Cell Physiol (2008) 3.10
Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J Proteome Res (2010) 3.08
The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem (2004) 2.46
GOAT links dietary lipids with the endocrine control of energy balance. Nat Med (2009) 2.42
Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol Cell Proteomics (2009) 2.39
An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med (2013) 2.23
Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Mol Cell Proteomics (2009) 2.09
Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. Biochemistry (2006) 2.06
Tissue heterogeneity of the mammalian mitochondrial proteome. Am J Physiol Cell Physiol (2006) 1.97
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology (2010) 1.91
Comprehensive label-free method for the relative quantification of proteins from biological samples. J Proteome Res (2005) 1.81
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science (2003) 1.77
Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. J Biol Chem (2003) 1.74
Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.68
New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J Neurosci (2007) 1.62
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther (2002) 1.43
Mathematical Nanotoxicoproteomics: Quantitative Characterization of Effects of Multi-walled Carbon Nanotubes (MWCNT) and TiO2 Nanobelts (TiO2-NB) on Protein Expression Patterns in Human Intestinal Cells. Curr Comput Aided Drug Des (2016) 1.39
A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis. Anal Biochem (2004) 1.38
Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal Chem (2007) 1.36
A multiple reaction monitoring method for absolute quantification of the human liver alcohol dehydrogenase ADH1C1 isoenzyme. Anal Biochem (2007) 1.32
Estimating the statistical significance of peptide identifications from shotgun proteomics experiments. J Proteome Res (2007) 1.30
The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. Gastroenterology (2012) 1.28
Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer. Clin Cancer Res (2006) 1.23
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom (2006) 1.22
Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin Appl (2008) 1.22
In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. J Nucl Med (2003) 1.22
Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation (2013) 1.22
Biochemical analysis of the damage recognition process in nucleotide excision repair. J Biol Chem (2002) 1.20
Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes (2004) 1.18
Effects of polymer wrapping and covalent functionalization on the stability of MWCNT in aqueous dispersions. J Colloid Interface Sci (2010) 1.18
Altitude ammonia-oxidizing bacteria and archaea in soils of Mount Everest. FEMS Microbiol Ecol (2009) 1.17
Proteomic analysis of blastema formation in regenerating axolotl limbs. BMC Biol (2009) 1.16
Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun (2002) 1.14
Silver nanoparticle protein corona composition in cell culture media. PLoS One (2013) 1.13
A novel alignment method and multiple filters for exclusion of unqualified peptides to enhance label-free quantification using peptide intensity in LC-MS/MS. J Proteome Res (2011) 1.12
Identification of serum N-acetylmuramoyl-l-alanine amidase as liver peptidoglycan recognition protein 2. Biochim Biophys Acta (2005) 1.09
Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes (2003) 1.08
Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. J Neurosci (2009) 1.07
Differential effects of ethanol in the nucleus accumbens shell of alcohol-preferring (P), alcohol-non-preferring (NP) and Wistar rats: a proteomics study. Pharmacol Biochem Behav (2009) 1.06
Fast top-down intact protein characterization with capillary zone electrophoresis-electrospray ionization tandem mass spectrometry. Anal Chem (2013) 1.06
Comparison of nanotube-protein corona composition in cell culture media. Small (2013) 1.06
LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS One (2009) 1.05
Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domain. Proc Natl Acad Sci U S A (2014) 1.05
The role of mass spectrometry in biomarker discovery and measurement. Curr Drug Metab (2006) 1.03
Zebrafish peptidoglycan recognition proteins are bactericidal amidases essential for defense against bacterial infections. Immunity (2007) 1.02
Application of pressure cycling technology to tissue sample preparation for 2-DE. Electrophoresis (2007) 1.02
Proteomic analysis of human aqueous humor using multidimensional protein identification technology. Mol Vis (2009) 1.01
Capillary zone electrophoresis-electrospray ionization-tandem mass spectrometry for top-down characterization of the Mycobacterium marinum secretome. Anal Chem (2014) 1.01
Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS). Mol Cell Proteomics (2013) 1.01
Human ribosomal protein S3 interacts with DNA base excision repair proteins hAPE/Ref-1 and hOGG1. Biochemistry (2004) 1.00
Multi-dimensional liquid chromatography in proteomics--a review. Anal Chim Acta (2010) 1.00
Structural and functional analyses of liver cysts from the BALB/c-cpk mouse model of polycystic kidney disease. Exp Biol Med (Maywood) (2008) 0.97
Identification of methylation and acetylation sites on mouse histone H3 using matrix-assisted laser desorption/ionization time-of-flight and nanoelectrospray ionization tandem mass spectrometry. J Protein Chem (2003) 0.97
CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation. Mol Cell Biol (2007) 0.96
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol (2013) 0.96
Alloxan is an inhibitor of O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem Biophys Res Commun (2006) 0.94
Nanoscale twinned copper nanowire formation by direct electrodeposition. Small (2009) 0.94
Label-free LC-MS method for the identification of biomarkers. Methods Mol Biol (2008) 0.93
Sample preparation for two-dimensional gel electrophoresis using pressure cycling technology. Anal Biochem (2007) 0.93
Genetic diversity of Ophiocordyceps sinensis, a medicinal fungus endemic to the Tibetan Plateau: implications for its evolution and conservation. BMC Evol Biol (2009) 0.92
Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling. Biochemistry (2009) 0.92
Impaired collateral development in mature rats. Am J Physiol Heart Circ Physiol (2002) 0.92
Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry. Brief Funct Genomic Proteomic (2007) 0.92
A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers. J Cell Biochem (2007) 0.92
Variability of protein content in calcium oxalate monohydrate stones. J Endourol (2006) 0.92
High diversity of the fungal community structure in naturally-occurring Ophiocordyceps sinensis. PLoS One (2010) 0.91
Synaptosome proteomics. Subcell Biochem (2007) 0.91
Characterization of human ribosomal protein S3 binding to 7,8-dihydro-8-oxoguanine and abasic sites by surface plasmon resonance. DNA Repair (Amst) (2004) 0.91
Role of interference between localized and propagating surface waves on the extraordinary optical transmission through a subwavelength-aperture array. Phys Rev Lett (2008) 0.89
Quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Biotechniques (2005) 0.89
Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer. Cancer Chemother Pharmacol (2008) 0.89
Cloning, expression, and characterization of two novel cuticle-degrading serine proteases from the entomopathogenic fungus Cordyceps sinensis. Res Microbiol (2008) 0.88
A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States. J Surg Res (2008) 0.88
Proteomic study of low-temperature responses in strawberry cultivars (Fragaria x ananassa) that differ in cold tolerance. Plant Physiol (2012) 0.88
Impact of genetic background and aging on mesenteric collateral growth capacity in Fischer 344, Brown Norway, and Fischer 344 x Brown Norway hybrid rats. Am J Physiol Heart Circ Physiol (2007) 0.88
Alterations in the aqueous humor proteome in patients with Fuchs endothelial corneal dystrophy. Mol Vis (2010) 0.88
Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg (2004) 0.88
Proteomic analysis of hearts from Akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy. J Proteome Res (2013) 0.87
A systems biology approach to the study of cisplatin drug resistance in ovarian cancers. J Bioinform Comput Biol (2007) 0.87
Effect of carbon nanoparticles on renal epithelial cell structure, barrier function, and protein expression. Nanotoxicology (2010) 0.87
Structured metal film as a perfect absorber. Adv Mater (2013) 0.86
Dual-mode electromagnetically induced transparency and slow light in a terahertz metamaterial. Opt Lett (2014) 0.86
Freely tunable broadband polarization rotator for terahertz waves. Adv Mater (2014) 0.86